Geneva, June 20 -- International Clinical Trials Registry received information related to the study (ISRCTN26924191) titled 'Effects of a mushroom blend on gastrointestinal symptoms and the microbiome' on June 10.
Study Type: Interventional
Study Design:
Randomized double-blind parallel-group placebo-controlled clinical trial (Quality of life, Efficacy)
Primary Sponsor: Substantiation Sciences, LLC
Condition:
Gastrointestinal health
Digestive System
Intervention:
This is a 6-week, double-blind, randomized controlled trial. Randomization will be carried out in Excel using the RANDO function. Participants will be stratified by sex and block randomization will be applied to ensure balanced groups across both sexes.Those randomized i...